Jose Escribano, founder of Spanish biotech success story ALGENEX, discusses the company’s focus on using insects in its research, difficulties in accessing capital, and its future growth strategy.
Can you please start by describing the opportunities that presented themselves, allowing you to create ALGENEX?
"What we have done is to reconceptualize the recombinant protein manufacturing process by taking inspiration from nature and striving to harness organisms that evolved from millions of years of evolution. "
